Peptides •
Carbetocin •
Demoxytocin •
Lipo-oxytocin-1 •
Merotocin •
Oxytocin •
Vasotocin Non-peptides •
LIT-001 — improved
social deficits in mice; non-selective over vasopressin receptors •
LIT-002 – highly potent, under formal development •
TC OT 39 – non-selective over vasopressin receptors •
WAY-267,464 –
anxiolytic in mice; possibly non-selective over vasopressin receptors In April 2025, a series of novel and highly potent small-molecule oxytocin receptor agonists with high selectivity over the vasopressin
V1A receptor (up to >5,000-fold) were
patented and described.
Unknown •
NP-1031 Indirect •
KNX-100 (SOC-1) –
pro-social and
anti-addictive effects ==References==